Contact Molecules for Homologous Proteins | ||||
[Summary Bars] |
[Full Bars] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
2931865 | 365 | 94 | P04439(HLAA_HUMAN) | RecName: Full=HLA class I histocompatibility antigen, A alpha chain;AltName: Full=Human leukocyte antigen A; Short=HLA-A;Flags: Precursor; |
QUERYSEQ |
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYRQDAYDGKDYIAL NEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEL SSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV |
All | LB/B (likely benign or benign) | ||
Number of sites | 365 | 70 | |
Buired or Exposed | Buried | 37.6 (%) [105] | 32.7 (%) [17] |
Exposed | 62.4 (%) [174] | 67.3 (%) [35] | |
Ave relacc | 33.4 % | 34.7 % | |
SD relacc | 26.31 % | 22.78 % | |
Contact Mol | hetero | 34.8 (%) [127] | 50.0 (%) [35] |
nucleotide | 0.0 (%) [0] | 0.0 (%) [0] | |
compound | 0.0 (%) [0] | 0.0 (%) [0] | |
metal | 7.7 (%) [28] | 8.6 (%) [6] | |
otherpoly | 1.1 (%) [4] | 0.0 (%) [0] | |
homo | 4.1 (%) [15] | 4.3 (%) [3] | |
precipitant | 38.4 (%) [140] | 37.1 (%) [26] | |
Number of variants | 92 | 92 | |
N_Freq(AAvariant)==0 % | 4.3 % [4] | ||
N_Freq(AAvariant)>0 % | 95.7 % [88] | ||
Ave Freq(AAvariant) | 8.9 % | ||
SD Freq(AAvariant) | 8.43 % |
70 sites | 3,5,10,14,23,33,41,55,59,67,68,80,86,87,89,90,91,94,97,98,100,101,114,119,121,123,129,131,133,138,140,151,166,168,169,173,174,175,176,180,182,185,187,190,191,195,208,210,217,218,231,269,270,277,279,292,300,306,307,312,318,321,322,323,331,334,335,338,345,358 |
[n]:site number of query sequence. [a]:amino acid of query sequence. [s]:predicted secondary structure. [e]:predicted exposed/buried. [acc]:predicted relative accesssibility(%). [pdb]:PDB code of homologous structure. [contact_mols]:predicted binding molecules [observed aa]:Observed amino acids among homologous sequences. [feature table]:UniProt Feature Table [variant]:UniProt Human Variant.
n | a | s | e | acc | pdb | contact_mols | observed aa | feature table | variant |
3 | V | - | - | - | - | VAFTILS |
REGION /note="VL9 epitope" SIGNAL REGION /note="VL9 epitope" DISORDER predicted by DISOPRED SIGNAL | V->I:(4.0 %):LB/B - | |
5 | A | - | - | - | - | ALVGMRP |
REGION /note="VL9 epitope" SIGNAL REGION /note="VL9 epitope" DISORDER predicted by DISOPRED SIGNAL | A->P:(1.0 %):LB/B - | |
10 | L | - | - | - | - | LFVI |
REGION /note="VL9 epitope" SIGNAL REGION /note="VL9 epitope" DISORDER predicted by DISOPRED SIGNAL | L->V:(7.0 %):LB/B - | |
14 | S | - | - | - | - | ASHLIKT |
SIGNAL DISORDER predicted by DISOPRED SIGNAL | S->L:(7.0 %):LB/B - | |
23 | W | - | - | - | - | WRQVGPCDHLNAEIKST |
SIGNAL SIGNAL | W->R:(11.0 %):LB/B - | |
33 | F | E | b | 3.3 | 6o9c_A | hetero B2MG_HUMAN RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN R4P6M5_9INFA R4X2K3_9INFA NS1_INBSJ RASK_HUMAN | FYLVHIRSEQDT |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | F->S:(6.0 %):LB/B - dbSNP:rs2075684;F->T:(1.0 %):LB/B -;F->Y:(22.0 %):LB/B - dbSNP:rs2075684 |
41 | R | S | e | 68.4 | 6o9c_A | hetero B2MG_HUMAN metal CL precipitant | RLPSTHEKAIYF |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | R->S:(13.0 %):LB/B - dbSNP:rs1059423 |
55 | T | E | e | 20.8 | 6o9c_A | QTLEKHR |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | T->S:(0.0 %):LB/B - | |
59 | R | E | e | 22.5 | 6o9c_A | hetero B2MG_HUMAN precipitant | RHGTSKPAFMQW |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | R->Q:(1.0 %):LB/B - |
67 | Q | e | 38.3 | 6o9c_A | hetero homo | PRAQGDKSTNEILV |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | Q->R:(18.0 %):LB/B - dbSNP:rs4155911 | |
68 | R | S | e | 33.2 | 6o9c_A | homo precipitant | RIKQETFLSAG |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | R->K:(10.0 %):LB/B - |
80 | G | e | 21.4 | 6o9c_A | GASVLREDFIKNPQTY |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | G->E:(4.0 %):LB/B -;G->R:(5.0 %):LB/B - dbSNP:rs1059449 | ||
86 | Q | H | e | 54.1 | 6o9c_A | hetero A0A087WSZ9_HUMAN K7N5N2_HUMAN NEF_HV1Z6 A14_VACCW NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA PK3CA_HUMAN NS1_INBSJ precipitant | RKQNGETHL |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | Q->E:(7.0 %):LB/B -;Q->G:(8.0 %):LB/B -;Q->L:(1.0 %):LB/B -;Q->R:(35.0 %):LB/B - |
87 | E | H | b | 15.6 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ RASK_HUMAN | EQVSGLNYDT |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | E->N:(5.0 %):LB/B -;E->Q:(14.0 %):LB/B - |
89 | R | H | e | 63.2 | 6o9c_A | hetero A0A087WSZ9_HUMAN K7N5N2_HUMAN precipitant | QETRAGFKDMNLW |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | R->G:(7.0 %):LB/B - dbSNP:rs1994744 |
90 | N | H | e | 58.8 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW A0A087WSZ9_HUMAN K7N5N2_HUMAN CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ RASK_HUMAN precipitant | DKNISLATEMRVY |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | N->K:(14.0 %):LB/B - dbSNP:rs1994744 |
91 | V | H | b | 3.3 | 6o9c_A | hetero PK3CA_HUMAN SPIKE_SARS2 POL_HV1Z2 A14_VACCW NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 R4P6M5_9INFA NCAP_INBAC RASK_HUMAN | LAWFIQDGSVYCMT |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | V->M:(1.0 %):LB/B - |
94 | Q | H | b | 14.8 | 6o9c_A | hetero SPIKE_SARS2 RASN_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW PK3CA_HUMAN NCAP_INBSI M1_INBAC NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ NCAP_I46A1 precipitant | QNWEVKMRHLTDFS |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | Q->H:(4.0 %):LB/B - dbSNP:rs7830686 |
97 | T | H | e | 40.9 | 6o9c_A | hetero SPIKE_SARS2 PK3CA_HUMAN RASN_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ | TVLIQSMRDAFKNW |
BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | T->I:(11.0 %):LB/B - dbSNP:rs1994744 |
98 | D | H | b | 0.0 | 6o9c_A | hetero SPIKE_SARS2 RASN_HUMAN | FLEYDNS |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | D->H:(0.0 %):LB/B -;D->N:(6.0 %):LB/B - |
100 | V | H | e | 57.3 | 6o9c_A | hetero PK3CA_HUMAN NEF_HV1Z6 KI2S2_HUMAN M1_INBAC NCAP_I46A1 POL_HV1Z2 Q9YV12_9HIV1 Q9YYU8_9HIV1 R4X2K3_9INFA SPIKE_SARS2 NS1_INBSJ | VELIADGMRST |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | V->A:(4.0 %):LB/B -;V->E:(14.0 %):LB/B - dbSNP:rs1071742 |
101 | D | H | e | 32.7 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ RASK_HUMAN | DENTFSAGMV |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | D->N:(13.0 %):LB/B - dbSNP:rs1136688;D->S:(7.0 %):LB/B - |
114 | A | T | e | 61.6 | 6o9c_A | hetero precipitant | DGAKESTFILVNPQRY |
REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" | A->D:(18.0 %):LB/B - dbSNP:rs1136692 |
119 | I | E | b | 4.1 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN NEF_HV1Z6 CTNB1_HUMAN NCAP_INBSI NCAP_I46A1 Q9YYU8_9HIV1 NCAP_INBAC RASK_HUMAN | LIVFYMR |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | I->L:(46.0 %):LB/B - dbSNP:rs1071743;I->V:(12.0 %):LB/B - |
121 | I | E | b | 2.9 | 6o9c_A | hetero B2MG_HUMAN SPIKE_SARS2 A14_VACCW PK3CA_HUMAN POL_HV1Z2 RASN_HUMAN NS1_INBSJ precipitant | VGAWRIFDEMLST |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | I->M:(4.0 %):LB/B - dbSNP:rs1136695;I->R:(8.0 %):LB/B - |
123 | Y | E | b | 10.0 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ RASK_HUMAN | YALGMFHIRSPEN |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | Y->F:(6.0 %):LB/B - dbSNP:rs1136697 |
129 | S | T | e | 79.7 | 6o9c_A | precipitant | SEPNAHTRYILF |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | S->P:(14.0 %):LB/B - dbSNP:rs1136700 |
131 | G | S | b | 17.9 | 6o9c_A | precipitant | GNTEQRSW |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | G->W:(1.0 %):LB/B - dbSNP:rs1136702 |
133 | F | E | e | 34.9 | 6o9c_A | FLSARTGIYHPVDEKNQ |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | F->L:(14.0 %):LB/B - dbSNP:rs1059488 | |
138 | R | E | b | 12.3 | 6o9c_A | hetero SPIKE_SARS2 RASN_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN PK3CA_HUMAN M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ metal CL precipitant | LWEAFRVDKNQGHIMSTYCP |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | R->E:(14.0 %):LB/B -;R->H:(2.0 %):LB/B -;R->Q:(3.0 %):LB/B - |
140 | D | E | b | 8.6 | 6o9c_A | hetero B2MG_HUMAN RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ RASK_HUMAN | YFVLGEAHDMISKNPRT |
BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | D->H:(5.0 %):LB/B -;D->Y:(22.0 %):LB/B - |
151 | N | e | 27.3 | 6o9c_A | hetero TPSN_HUMAN precipitant | DNQKCERTW |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | N->K:(9.0 %):LB/B - dbSNP:rs1059509 | |
166 | I | H | e | 34.5 | 6o9c_A | hetero SPIKE_SARS2 KI2S2_HUMAN TPSN_HUMAN precipitant | IPVKFWQTALRGNMS |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | I->T:(5.0 %):LB/B - dbSNP:rs1059516 |
168 | K | H | b | 17.5 | 6o9c_A | KAQNRCETGSDL |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | K->Q:(11.0 %):LB/B - | |
169 | R | H | e | 58.1 | 6o9c_A | hetero KI2S2_HUMAN TPSN_HUMAN precipitant | ERLKQDVAHFMNSTI |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | R->H:(4.0 %):LB/B - dbSNP:rs1059520 |
173 | A | H | e | 64.3 | 6o9c_A | hetero KI2S2_HUMAN precipitant | SAKYNQLTDPVEGRCH |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | A->T:(5.0 %):LB/B - dbSNP:rs1059526 |
174 | A | T | e | 54.5 | 6o9c_A | hetero RASN_HUMAN POL_HV1Z2 NEF_HV1Z6 KI2S2_HUMAN A14_VACCW PK3CA_HUMAN NCAP_INBSI NCAP_CVHSA Q9YV12_9HIV1 R4X2K3_9INFA SPIKE_SARS2 M1_INBAC NS1_INBSJ RASK_HUMAN precipitant | QALDKEINVYHRST |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | A->V:(5.0 %):LB/B - |
175 | H | T | e | 56.5 | 6o9c_A | hetero KI2S2_HUMAN PDIA3_HUMAN M1_INBAC metal CL precipitant | KPGHRSDYNMAEFILQCV |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | H->R:(8.0 %):LB/B - |
176 | E | H | e | 33.7 | 6o9c_A | hetero SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NEF_HV1Z6 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC RASN_HUMAN NS1_INBSJ RASK_HUMAN metal CL precipitant | EDIKRYGTAQFVLW |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | E->A:(4.0 %):LB/B -;E->R:(7.0 %):LB/B -;E->V:(2.0 %):LB/B - dbSNP:rs9256983;E->W:(1.0 %):LB/B - |
180 | L | H | b | 14.6 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NCAP_INBAC NS1_INBSJ metal CL | VKTALRSIEFHNQDMWY |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | L->Q:(4.0 %):LB/B -;L->R:(8.0 %):LB/B -;L->W:(1.0 %):LB/B - dbSNP:rs9260156 |
182 | A | H | e | 51.8 | 6o9c_A | hetero A0A087WSZ9_HUMAN K7N5N2_HUMAN precipitant | ANTHKQSDIRVWEGLY |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | A->V:(2.0 %):LB/B - |
185 | D | H | e | 37.7 | 6o9c_A | hetero precipitant | DESNLKHQRTGY |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | D->E:(25.0 %):LB/B - dbSNP:rs1059542 |
187 | T | H | e | 45.5 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 A0A087WSZ9_HUMAN K7N5N2_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW NCAP_INBSI M1_INBAC NCAP_CVHSA MYPR_HUMAN Q9YYU8_9HIV1 R4P6M5_9INFA R4X2K3_9INFA NS1_INBSJ NCAP_I46A1 RASK_HUMAN precipitant | TVDEYINSLAGKMP |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | T->E:(10.0 %):LB/B -;T->R:(0.0 %):LB/B - |
190 | E | H | e | 36.2 | 6o9c_A | hetero precipitant | EQRHAGLSDMTFIKNPVY |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | E->D:(2.0 %):LB/B - dbSNP:rs8795778 |
191 | W | H | e | 25.9 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA NCAP_INBAC NS1_INBSJ RASK_HUMAN precipitant | WFYQLNRSIMEKTADGHPVC |
REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | W->G:(2.0 %):LB/B - dbSNP:rs3098019 |
195 | Y | H | b | 1.7 | 6o9c_A | hetero RASN_HUMAN SPIKE_SARS2 PK3CA_HUMAN POL_HV1Z2 NEF_HV1Z6 A14_VACCW CTNB1_HUMAN NCAP_INBSI M1_INBAC NCAP_I46A1 NCAP_CVHSA MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 R4P6M5_9INFA NCAP_INBAC NS1_INBSJ RASK_HUMAN | YHFLNVEIG |
BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" | Y->H:(12.0 %):LB/B - |
208 | P | e | 47.3 | 6o9c_A | PEKQARSCFHT |
REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DISORDER predicted by DISOPRED REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | P->A:(5.0 %):LB/B - | ||
210 | K | E | e | 68.4 | 6o9c_A | hetero B2MG_HUMAN metal NA homo | KVESTLMQNRD |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DISORDER predicted by DISOPRED DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | K->R:(2.0 %):LB/B - |
217 | P | E | e | 72.9 | 6o9c_A | precipitant | PENSQVAKRW |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | P->A:(2.0 %):LB/B - |
218 | I | S | e | 55.0 | 6o9c_A | precipitant | VALSTIYGREPFDNQ |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | I->V:(18.0 %):LB/B - |
231 | G | E | b | 16.7 | 6o9c_A | GDNSKQR |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | G->S:(7.0 %):LB/B - | |
269 | A | E | b | 0.0 | 6o9c_A | VASHCLMNYEI |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | A->V:(34.0 %):LB/B - | |
270 | A | E | b | 4.5 | 6o9c_A | SYTAMHLVERFKI |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | A->S:(20.0 %):LB/B - | |
277 | E | e | 36.2 | 6o9c_A | EDSQNRKPATVLYGH |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | E->K:(4.0 %):LB/B -;E->Q:(9.0 %):LB/B - | ||
279 | Q | G | e | 38.3 | 6o9c_A | DQAEHPSTVNK |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | Q->K:(1.0 %):LB/B - | |
292 | K | S | e | 77.8 | 6o9c_A | QEKSDMARTGHNV |
DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" | K->E:(25.0 %):LB/B - | |
300 | L | e | 48.3 | 6o9c_A | APLSFKEHQCGNTDIRV |
REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" | L->P:(21.0 %):LB/B - | ||
306 | I | - | - | - | - | ILVMSRWEQKFTADGNP |
REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" | I->V:(12.0 %):LB/B - | |
307 | P | - | - | - | - | PSLGIATVKMNQYDEFR |
REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" | P->H:(0.0 %):LB/B - | |
312 | I | - | - | - | - | VISALFGMT |
TRANSMEM /note="Helical" TRANSMEM /note="Helical" | I->L:(4.0 %):LB/B - | |
318 | L | - | - | - | - | LVFIACGYDEKNPQRST |
TRANSMEM /note="Helical" TRANSMEM /note="Helical" | L->F:(7.0 %):LB/B - | |
321 | V | - | - | - | - | VILAGFMT |
TRANSMEM /note="Helical" TRANSMEM /note="Helical" | V->M:(1.0 %):LB/B - | |
322 | I | - | - | - | - | IVLAFMTG |
TRANSMEM /note="Helical" TRANSMEM /note="Helical" | I->F:(4.0 %):LB/B - | |
323 | T | - | - | - | - | VATILCFGMSEK |
TRANSMEM /note="Helical" TRANSMEM /note="Helical" | T->A:(19.0 %):LB/B - | |
331 | M | - | - | - | - | MLIFGVRSAC |
TRANSMEM /note="Helical" TRANSMEM /note="Helical" | M->R:(6.0 %):LB/B - | |
334 | R | - | - | - | - | RKS |
TOPO_DOM /note="Cytoplasmic" TOPO_DOM /note="Cytoplasmic" | R->K:(17.0 %):LB/B - | |
335 | K | - | - | - | - | KRMSWGNQAHV |
TOPO_DOM /note="Cytoplasmic" TOPO_DOM /note="Cytoplasmic" | K->N:(5.0 %):LB/B - | |
338 | D | - | - | - | - | GESDRAVP |
TOPO_DOM /note="Cytoplasmic" TOPO_DOM /note="Cytoplasmic" | D->V:(4.0 %):LB/B - | |
345 | T | - | - | - | - | TSVANQI |
COMPBIAS /note="Polar residues" REGION /note="Disordered" TOPO_DOM /note="Cytoplasmic" COMPBIAS /note="Polar residues" REGION /note="Disordered" DISORDER predicted by DISOPRED TOPO_DOM /note="Cytoplasmic" | T->S:(25.0 %):LB/B - | |
358 | V | - | - | - | - | VIMLED |
COMPBIAS /note="Polar residues" REGION /note="Disordered" TOPO_DOM /note="Cytoplasmic" COMPBIAS /note="Polar residues" REGION /note="Disordered" DISORDER predicted by DISOPRED TOPO_DOM /note="Cytoplasmic" | V->M:(14.0 %):LB/B - |